By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biotium's GelRed will be incorporated into Elchrom Scientific's pre-cast gels for HLA typing and sold globally as part of an agreement announced by the companies today.

Switzerland-based Elchrom develops materials and methods for separating nucleic acids. The HLA Ready-to-Use Gels with GelRed are the first of its kind to be stained with GelRed and offers eight-channel capability for up to 96 sample testing simultaneously within seven minutes, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.